标题
Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 35, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-09-27
DOI
10.1186/s13046-016-0433-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer
- (2016) Giorgio Scagliotti et al. INVESTIGATIONAL NEW DRUGS
- The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs
- (2015) R Visconti et al. CELL DEATH AND DIFFERENTIATION
- Will Targeting Chk1 Have a Role in the Future of Cancer Therapy?
- (2015) Nandini Sakurikar et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
- (2015) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
- (2015) Khanh Do et al. JOURNAL OF CLINICAL ONCOLOGY
- Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer
- (2015) Jingtao Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression
- (2015) Rosa Della Monica et al. eLife
- Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
- (2015) Rosaria Chilà et al. Oncotarget
- Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors
- (2014) Edward Sausville et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents
- (2014) Lingli Zhou et al. CELL BIOLOGY INTERNATIONAL
- Inhibition of Aurora B by CCT137690 sensitizes colorectal cells to radiotherapy
- (2014) Xiaoyu Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification of a mitotic death signature in cancer cell lines
- (2013) Nandini Sakurikar et al. CANCER LETTERS
- Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway
- (2013) Guohui Wan et al. CELLULAR SIGNALLING
- Mitosis and apoptosis: how is the balance set?
- (2013) Caroline H Topham et al. CURRENT OPINION IN CELL BIOLOGY
- Tumour selective targeting of cell cycle kinases for cancer treatment
- (2013) Marieke Aarts et al. CURRENT OPINION IN PHARMACOLOGY
- Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents
- (2013) Hala Bakr El-Nassan EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
- (2013) A. D. Guertin et al. MOLECULAR CANCER THERAPEUTICS
- The ATM protein kinase: regulating the cellular response to genotoxic stress and more
- (2013) Yosef Shiloh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
- (2012) Cynthia X. Ma et al. BREAST CANCER RESEARCH AND TREATMENT
- The end of mitosis from a phosphatase perspective
- (2012) Roberta Visconti et al. CELL CYCLE
- CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
- (2012) M. I. Walton et al. CLINICAL CANCER RESEARCH
- Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias
- (2012) J. E. Karp et al. CLINICAL CANCER RESEARCH
- Mechanisms of replication fork protection: a safeguard for genome stability
- (2012) Alessia Errico et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption
- (2012) H. Beck et al. MOLECULAR AND CELLULAR BIOLOGY
- WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas
- (2012) V. Caretti et al. MOLECULAR CANCER THERAPEUTICS
- Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit
- (2012) Roberta Visconti et al. Nature Communications
- Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
- (2012) Marieke Aarts et al. Cancer Discovery
- Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines
- (2011) A Peasland et al. BRITISH JOURNAL OF CANCER
- MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
- (2011) N. V. Rajeshkumar et al. CLINICAL CANCER RESEARCH
- MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
- (2011) K. A. Bridges et al. CLINICAL CANCER RESEARCH
- Peptidyl Prolyl Isomerase, Pin1 is a Potential Target for Enhancing the Therapeutic Efficacy of Etoposide
- (2011) R. Mathur et al. CURRENT CANCER DRUG TARGETS
- Targeting the S and G2 checkpoint to treat cancer
- (2011) Tao Chen et al. DRUG DISCOVERY TODAY
- MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells
- (2011) J. M. Kreahling et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites
- (2011) R. Montano et al. MOLECULAR CANCER THERAPEUTICS
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- miRNA response to DNA damage
- (2011) Guohui Wan et al. TRENDS IN BIOCHEMICAL SCIENCES
- MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
- (2010) Hiroshi Hirai et al. CANCER BIOLOGY & THERAPY
- Phosphorylation of Mcl-1 by CDK1–cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest
- (2010) Margaret E Harley et al. EMBO JOURNAL
- A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial
- (2010) Tianhong Li et al. INVESTIGATIONAL NEW DRUGS
- How do anti-mitotic drugs kill cancer cells?
- (2009) K. E. Gascoigne et al. JOURNAL OF CELL SCIENCE
- The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
- (2009) Yuan Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
- (2009) L. A. Parsels et al. MOLECULAR CANCER THERAPEUTICS
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1
- (2008) A. Blasina et al. MOLECULAR CANCER THERAPEUTICS
- ATR: an essential regulator of genome integrity
- (2008) Karlene A. Cimprich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started